Home
About
Technology
- innov’SAR Platform
- Computational Resources
Services
- How PEACCEL Can Support You
- Examples
News
Contact

Management

PEACCEL
Management
Laurent Contaut

Laurent Contaut

EducationMSc in Healthcare Engineering

Laurent Contaut

24 years of international experience in the pharma / biotech / medtech space

About PEACCEL

PEACCEL developed a unique and versatile AI-platform named innov’SAR that allows predicting multiple types of innovation in Life Sciences and biotechnology. PEACCEL provides solutions to make risky and investment intensive drug and enzyme development more efficient. Innovation cycles become with innov’SAR faster, more calculatable, and yield better results at lower costs compared to conventional methods.

Recent News

The CEO of PEACCEL, Laurent Contaut, has been awarded “CEO of the Year 2021” by AI Global Media Ltd
PEACCEL mentioned as a AI start-up to watch by NVIDIA
PEACCEL listed in the Global AI-based Drug Discovery Market Report 2021: Market report by Cision (NYSE: CISN).

Search

Search for:

Credits

Legal notice
Sitemap

© 2020 PEACCEL. All Rights Reserved.